Myriad Genetic Laboratories

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:Genetics
gptkbp:academic_programs maintained
gptkbp:acquisition gptkb:Myriad_Genetics,_Inc.
gptkbp:awards received multiple industry awards
gptkbp:ceo Paul J. Diaz
gptkbp:clinical_trial ongoing
gptkbp:clinical_utility established
gptkbp:clinical_validity demonstrated
gptkbp:collaborations with academic institutions
ongoing with universities
gptkbp:community_outreach active
gptkbp:competitors gptkb:Invitae
gptkb:23and_Me
gptkb:Color_Genomics
gptkbp:conference participates in medical conferences
gptkbp:data_privacy ensured
gptkbp:employees over 1,000
gptkbp:financial_support available
gptkbp:focus cancer risk assessment
gptkbp:founded gptkb:1991
gptkbp:founder gptkb:Mark_C._Capone
gptkbp:genetic_counselors employed
gptkbp:headquarters gptkb:Salt_Lake_City,_Utah
gptkbp:healthcare improved
gptkbp:healthcare_integration promoted
https://www.w3.org/2000/01/rdf-schema#label Myriad Genetic Laboratories
gptkbp:innovation focus on innovative testing solutions
gptkbp:invention numerous genetic testing patents
gptkbp:is_tested_for confidential
hereditary cancer tests
BRCA1 and BRCA2 testing
cardiovascular tests
neurodegenerative disease tests
pharmacogenomics tests
gptkbp:market genetic testing market
gptkbp:mission to improve patient care through genetic testing
gptkbp:partnership pharmaceutical companies
various healthcare providers
gptkbp:patient_education provided
gptkbp:provides_guidance_on followed
gptkbp:publications numerous
gptkbp:regulatory_compliance gptkb:FDA
ensured.
gptkbp:research_focus personalized medicine
gptkbp:revenue over $200 million annually
gptkbp:services genetic testing
gptkbp:stock_exchange gptkb:NASDAQ
gptkbp:technology advanced laboratory technology
gptkbp:test_accuracy high
gptkbp:test_interpretation provided by experts
gptkbp:testimonials available
gptkbp:type_of_insurance accepted
gptkbp:website myriad.com